查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599337

維生素 D 治療市場：途徑、購買模式、年齡層、適應症分類 - 2025-2030 年全球預測

Vitamin D Therapy Market by Route of Administration (Oral Route of Administration, Parenteral Route of Administration), Purchasing Pattern (Over-The-Counter Drugs, Prescription Drugs), Age Group, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

維生素D治療市場2023年估值為32億美元，預計2024年將達36.1億美元，複合年成長率為12.75%，預計到2030年將達到74.2億美元。

維生素 D 療法包括使用維生素 D 來預防和治療維生素 D 缺乏症和相關健康狀況，例如骨質疏鬆症、佝僂病和某些自體免疫疾病。對維生素 D 的需求是顯而易見的，因為它是維持骨骼健康和調節鈣和磷吸收的基本身體需求。應用包括營養食品、強化食品、處方藥和日光浴，最終用途包括陽光照射有限、飲食不足和某些健康狀況的人。主要市場成長要素包括由於人口老化導致的骨骼相關疾病風險增加、由於現代室內生活方式導致維生素 D 缺乏症盛行率增加以及人們認知到維生素 D 的健康益處。新的商機包括開發個人化維生素 D 療法、滿足客製化的健康需求以及探索新的遞送方法，例如提高生物利用度和功效的奈米製劑。利用這些機會的建議包括投資創新產品線的研發以及利用與醫療保健提供者的夥伴關係來教育消費者。然而，維生素 D 市場面臨著局限性和挑戰，包括維生素 D 毒性風險（尤其是在高劑量監管下）、補充品核准的監管障礙以及來自替代療法的競爭。此外，由於新興市場對補充品功效的認知不足和懷疑，市場成長可能會放緩。最佳創新領域包括研究維生素 D 的基因相關反應、針對缺乏症的非侵入性診斷工具以及針對營養高風險族群的強化食品。該市場是動態的，其特點是受科學進步和公共衛生趨勢影響而具有穩定成長的潛力，並且需要靈活的商業策略來適應不斷變化的消費者偏好和監管環境。

主要市場統計
基準年[2023] 32億美元
預測年份 [2024] 36.1億美元
預測年份 [2030] 74.2億美元
複合年成長率（%） 12.75%

市場動態：揭示快速發展的維生素 D 治療市場的關鍵市場洞察

供需的動態交互作用正在改變維生素 D 治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 美國維生素 D 缺乏症人數增加。
    • 存在大量目標患者群體
    • 人們對維生素 D 療法的認知不斷提高
  • 市場限制因素
    • 有限的臨床試驗
  • 市場機會
    • 營養不良發生率高的國家的成長機會增加
    • 活性化研發活動以有效開發維生素 D 療法
  • 市場挑戰
    • 強化食品的供應

波特五力：駕馭維生素 D 治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解維生素 D 治療市場的外部影響

外部宏觀環境因素在塑造維生素 D 治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解維生素 D 治療市場的競爭模式

維生素 D 治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣維生素 D 治療市場供應商的績效評估

FPNV 定位矩陣是評估維生素 D 治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了維生素 D 治療市場的成功之路

維生素 D 治療市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 美國維生素 D 缺乏症呈上升趨勢
      • 目標患者群廣泛
      • 提高維生素 D 療法的認知
    • 抑制因素
      • 有限的臨床試驗
    • 機會
      • 擴大營養不足發生率高的國家的成長機會
      • 增加研發活動以開發有效的維生素 D 療法
    • 任務
      • 強化食品的供應
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章維生素 D 治療市場：依給藥途徑

  • 口服給藥
  • 腸胃外給藥途徑

第7章維生素D治療市場（按購買模式）

  • 非處方藥
  • 處方藥

第8章維生素 D 治療市場：依年齡層

  • 成人
  • 孩子們

第9章維生素 D 治療市場（按適應症）

  • 自體免疫疾病
  • 肌肉無力
  • 骨質疏鬆症
  • 疳
  • 皮膚病

第10章美洲維生素D治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太維生素D治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲維生素D治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amway Corp.
  • Bayer AG
  • Bio-Tech Pharmacal, Inc.
  • GlaxoSmithKline PLC
  • Healthy Body LLC
  • Merck KGaA
  • Otsuka Holdings Co., Ltd
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Superior Supplement Manufacturing
  • The Zydus group
  • Vitablend Nederland BV
Product Code: MRR-4302AC721F94

The Vitamin D Therapy Market was valued at USD 3.20 billion in 2023, expected to reach USD 3.61 billion in 2024, and is projected to grow at a CAGR of 12.75%, to USD 7.42 billion by 2030.

Vitamin D therapy encompasses the use of vitamin D to prevent or treat deficiency and associated health conditions, including osteoporosis, rickets, and certain autoimmune diseases. Its necessity is underscored by the body's vital requirement for maintaining healthy bones and regulating calcium and phosphorus absorption. Application areas include dietary supplements, fortified foods, prescription medications, and sunlight exposure, with end-use spanning individuals with limited sun exposure, dietary deficiencies, and specific health conditions. Key market growth factors include an aging population more at risk for bone-related ailments, increasing prevalence of vitamin D deficiency due to modern indoor lifestyles, and growing awareness about the health benefits of vitamin D. Moreover, rising healthcare expenditures and advancements in vitamin D formulations further propel market demand. Emerging opportunities include the development of personalized vitamin D therapy, addressing tailored health needs, and exploring new delivery methods, like nanoscale formulations, for enhanced bioavailability and efficacy. Recommendations to capitalize on these opportunities include investing in R&D for innovative product lines and leveraging partnerships with healthcare providers to educate consumers. However, the market faces limitations and challenges such as risks of vitamin D toxicity, particularly in unsupervised, high-dose consumption, regulatory hurdles related to supplement approvals, and competition from alternative therapies. Furthermore, market growth could be slowed by a lack of awareness in developing regions and skepticism over supplementation benefits. Best areas of innovation include research on gene-related responses to vitamin D, non-invasive diagnostic tools for deficiency, and fortified foods targeting nutritionally at-risk populations. The market is dynamic, characterized by steady growth potential influenced by scientific advancements and public health trends, necessitating agile business strategies to adapt to evolving consumer preferences and regulatory landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 3.20 billion
Estimated Year [2024] USD 3.61 billion
Forecast Year [2030] USD 7.42 billion
CAGR (%) 12.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vitamin D Therapy Market

The Vitamin D Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of vitamin D deficiency in the U.S.
    • Presence of a large target patient population
    • Growing awareness regarding vitamin D therapy
  • Market Restraints
    • Limited clinical Trials
  • Market Opportunities
    • Increasing growth opportunities in countries with a high prevalence of undernutrition
    • Rise in R&D activities for development of efficient vitamin D therapies
  • Market Challenges
    • Availability of fortified foods

Porter's Five Forces: A Strategic Tool for Navigating the Vitamin D Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vitamin D Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vitamin D Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vitamin D Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vitamin D Therapy Market

A detailed market share analysis in the Vitamin D Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vitamin D Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vitamin D Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vitamin D Therapy Market

A strategic analysis of the Vitamin D Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vitamin D Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Amway Corp., Bayer AG, Bio-Tech Pharmacal, Inc., GlaxoSmithKline PLC, Healthy Body LLC, Merck KGaA, Otsuka Holdings Co., Ltd, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Superior Supplement Manufacturing, The Zydus group, and Vitablend Nederland B.V..

Market Segmentation & Coverage

This research report categorizes the Vitamin D Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Oral Route of Administration and Parenteral Route of Administration.
  • Based on Purchasing Pattern, market is studied across Over-The-Counter Drugs and Prescription Drugs.
  • Based on Age Group, market is studied across Adults and Children.
  • Based on Indication, market is studied across Autoimmune Disorders, Muscle Weakness, Osteoporosis, Rickets, and Skin Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of vitamin D deficiency in the U.S.
      • 5.1.1.2. Presence of a large target patient population
      • 5.1.1.3. Growing awareness regarding vitamin D therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Limited clinical Trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing growth opportunities in countries with a high prevalence of undernutrition
      • 5.1.3.2. Rise in R&D activities for development of efficient vitamin D therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of fortified foods
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vitamin D Therapy Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Oral Route of Administration
  • 6.3. Parenteral Route of Administration

7. Vitamin D Therapy Market, by Purchasing Pattern

  • 7.1. Introduction
  • 7.2. Over-The-Counter Drugs
  • 7.3. Prescription Drugs

8. Vitamin D Therapy Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Children

9. Vitamin D Therapy Market, by Indication

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Muscle Weakness
  • 9.4. Osteoporosis
  • 9.5. Rickets
  • 9.6. Skin Diseases

10. Americas Vitamin D Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vitamin D Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vitamin D Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alkem Laboratories Ltd.
  • 3. Amway Corp.
  • 4. Bayer AG
  • 5. Bio-Tech Pharmacal, Inc.
  • 6. GlaxoSmithKline PLC
  • 7. Healthy Body LLC
  • 8. Merck KGaA
  • 9. Otsuka Holdings Co., Ltd
  • 10. Pfizer Inc.
  • 11. Sanofi S.A.
  • 12. Sun Pharmaceutical Industries Ltd.
  • 13. Superior Supplement Manufacturing
  • 14. The Zydus group
  • 15. Vitablend Nederland B.V.

LIST OF FIGURES

  • FIGURE 1. VITAMIN D THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. VITAMIN D THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VITAMIN D THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VITAMIN D THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023